{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:01:16Z","timestamp":1760058076604,"version":"build-2065373602"},"reference-count":52,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The COVID-19 pandemic delayed the consultation of many patients with specialists. We present the case of a 57-year-old patient with HIV infection, COVID-19 pneumonia, and Hodgkin lymphoma. Discordant immunohistochemistry results from biopsy samples delayed the hematological diagnosis and initiation of oncological therapy. The late diagnosis of HIV infection at the stage of severe immunosuppression, along with advanced Hodgkin lymphoma and COVID-19 co-infection, represents a complex pathogenic triad that is challenging to manage. Healthcare-associated COVID-19 infections pose a significant risk during the pandemic for chronic patients requiring frequent hospital visits.<\/jats:p>","DOI":"10.3390\/v17030404","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T07:31:42Z","timestamp":1741764702000},"page":"404","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Managing HIV-Associated Hodgkin Lymphoma During the COVID-19 Pandemic: Case Report and Literature Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4237-2297","authenticated-orcid":false,"given":"Monica-Daniela","family":"Padurariu-Covit","sequence":"first","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Dunarea de Jos University of Galati, 800008 Galati, Romania"},{"name":"Hematology Department, Emergency County Hospital Sf. Apostol Andrei, 800578 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0532-7929","authenticated-orcid":false,"given":"Mihaela","family":"Andreescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Titu Maiorescu University, 031593 Bucharest, Romania"},{"name":"Hematology Department, Colentina Clinical Hospital, 020125 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9249-5247","authenticated-orcid":false,"given":"Elena","family":"Niculet","sequence":"additional","affiliation":[{"name":"Morphological and Functional Sciences Department, Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 800008 Galati, Romania"},{"name":"Morphological Department, Emergency County Hospital Sf. Apostol Andrei, 800578 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2710-7284","authenticated-orcid":false,"given":"Alina","family":"Plesea-Condratovici","sequence":"additional","affiliation":[{"name":"Medical Department, Medicine and Pharmacy Faculty, Dunarea de Jos University of Galati, 800008 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4762-0755","authenticated-orcid":false,"given":"Manuela","family":"Arbune","sequence":"additional","affiliation":[{"name":"Clinical Medical Department, Dunarea de Jos University of Galati, 800008 Galati, Romania"},{"name":"Infectious Diseases Clinic Hospital Sf. Cuv. Parascheva, 800179 Galati, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40258-020-00596-3","article-title":"The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis","volume":"18","author":"Alfano","year":"2020","journal-title":"Appl. Health Econ. Health Policy"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/jclinpath-2020-206833","article-title":"Cancer diagnostic rates during the 2020 \u2018lockdown\u2019, due to COVID-19 pandemic, compared with the 2018-2019: An audit study from cellular pathology","volume":"74","author":"Carr","year":"2021","journal-title":"J. Clin. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104953","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104953","article-title":"Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center","volume":"29","author":"Siegler","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2020.05.007","article-title":"The Impact of the Coronavirus Disease-2019 Pandemic and Italian Lockdown Measures on Clinical Presentation and Management of Acute Heart Failure","volume":"26","author":"Colivicchi","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/rth2.12391","article-title":"Pulmonary embolism during the COVID-19 pandemic: Decline in diagnostic procedures and incidence at a university hospital","volume":"4","author":"Nopp","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1017\/S0950268820001867","article-title":"Impact of coronavirus pandemic and containment measures on HIV diagnosis","volume":"148","author":"Darcis","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Arbune, M., Padurariu-Covit, M.D., Tiutiuca, C., Mihailov, R., Niculet, E., Arbune, A.A., and Tatu, A.L. (2024). Unusual Localization of AIDS-Related Kaposi\u2019s Sarcoma in a Heterosexual Male during the COVID-19 Pandemic: A Case Report. Trop. Med. Infect. Dis., 9.","DOI":"10.3390\/tropicalmed9020047"},{"key":"ref_9","first-page":"896","article-title":"Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis","volume":"94","author":"Gaddey","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2300269","DOI":"10.1200\/CCI.23.00269","article-title":"Extraction and Imputation of Eastern Cooperative Oncology Group Performance Status From Unstructured Oncology Notes Using Language Models","volume":"8","author":"Xu","year":"2024","journal-title":"JCO Clin. Cancer Inform."},{"key":"ref_12","unstructured":"CDC (1994). 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morb. Mortal. Wkly. Rep., 43, 1\u201310. Available online: https:\/\/www.cdc.gov\/mmwr\/pdf\/rr\/rr6303.pdf."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12308-023-00530-1","article-title":"PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma","volume":"16","author":"Shi","year":"2023","journal-title":"J. Hematop."},{"key":"ref_15","first-page":"3","article-title":"Pitfalls in the pathological diagnosis of lymphoma","volume":"4","author":"Li","year":"2015","journal-title":"Chin. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.6004\/jnccn.2022.0021","article-title":"NCCN Guidelines\u00ae Insights: Hodgkin Lymphoma, Version 2.2022","volume":"20","author":"Hoppe","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease. International Prognostic Factors Project on Advanced Hodgkin\u2019s Disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1182\/blood-2018-01-791400","article-title":"Optimizing treatment of HIV-associated lymphoma","volume":"134","author":"Noy","year":"2019","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2020.04.031","article-title":"The role of Neutrophil Extracellular Traps in COVID-19: Only an hypothesis or a potential new field of research?","volume":"191","author":"Mozzini","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2037069","DOI":"10.1001\/jamanetworkopen.2020.37069","article-title":"COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State","volume":"4","author":"Tesoriero","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","article-title":"Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis","volume":"11","author":"Ssentongo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/OLQ.0000000000001935","article-title":"Assessing the Impact of COVID-19 on HIV Outcomes in the United States: A Modeling Study","volume":"51","author":"Viguerie","year":"2024","journal-title":"Sex. Transm. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He","year":"2020","journal-title":"Leukemia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1097\/HS9.0000000000000538","article-title":"Risk Factors and Mortality of COVID-19 in Patients with Lymphoma: A Multicenter Study","volume":"5","author":"Navarro","year":"2021","journal-title":"Hemasphere"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: A European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"601709","DOI":"10.3389\/fonc.2021.601709","article-title":"Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed\/Refractory Hodgkin\u2019s Lymphoma","volume":"11","author":"Hindilerden","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_28","first-page":"71","article-title":"COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: A Case Report","volume":"20","author":"Fakharian","year":"2021","journal-title":"Tanaffos"},{"key":"ref_29","first-page":"e46950","article-title":"Recurrent COVID-19 Infection in a Refractory\/Classical Hodgkin\u2019s Lymphoma Patient Undergoing Autologous Stem Cell Transplantation: A Case Report","volume":"15","author":"Hamed","year":"2023","journal-title":"Cureus"},{"key":"ref_30","first-page":"1042","article-title":"Lymphoma as a Complication of Recurrent COVID-19 Infection in Patients with Rheumatic Disease","volume":"7","author":"Cartas","year":"2022","journal-title":"Ann. Case Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bulcan.2021.01.026","article-title":"Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH network","volume":"108","author":"Veyri","year":"2021","journal-title":"Bull. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/BLCTT.S361320","article-title":"HIV\/AIDS Associated Lymphoma: Review","volume":"12","author":"Berhan","year":"2022","journal-title":"Blood Lymphat. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2015-11-681411","article-title":"A lymphomagenic role for HIV beyond immune suppression?","volume":"127","author":"Dolcetti","year":"2016","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Navarro, J.T., Molt\u00f3, J., Tapia, G., and Ribera, J.M. (2021). Hodgkin Lymphoma in People Living with HIV. Cancers, 13.","DOI":"10.20944\/preprints202108.0420.v1"},{"key":"ref_35","unstructured":"European AIDS Clinical Society (EACS) (2024, December 10). Guideline Version 12.0 October 2023. Available online: https:\/\/www.eacsociety.org\/media\/guidelines-12.0.pdf."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17425255.2024.2408004","article-title":"Drug-drug interactions in HIV-infected patients receiving chemotherapy","volume":"21","author":"Branch","year":"2025","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.6004\/jnccn.2021.0054","article-title":"NCCN Guidelines\u00ae Insights: B-Cell Lymphomas, Version 5.2021","volume":"19","author":"Zelenetz","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0971-5851.177038","article-title":"Hodgkin lymphoma: A clinicopathological and immunophenotypic study","volume":"37","author":"Konkay","year":"2016","journal-title":"Indian J. Med. Paediatr. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.3390\/cimb46090596","article-title":"Immune Characteristics and Immunotherapy of HIV-Associated Lymphoma","volume":"46","author":"Liu","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1108837","DOI":"10.3389\/fonc.2023.1108837","article-title":"Multicolor flow cytometric assessment of Ki67 expression and its diagnostic value in mature B-cell neoplasms","volume":"13","author":"Mao","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Verdu-Bou, M., Tapia, G., Hernandez-Rodriguez, A., and Navarro, J.T. (2021). Clinical and Therapeutic Implications of Epstein-Barr Virus in HIV-Related Lymphomas. Cancers, 13.","DOI":"10.3390\/cancers13215534"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/cid\/ciy542","article-title":"Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas","volume":"68","author":"Muncunill","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1255533","DOI":"10.3389\/fimmu.2023.1255533","article-title":"Interleukin 6: At the interface of human health and disease","volume":"14","author":"Grebenciucova","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/bjh.19442","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative","volume":"204","author":"Ganapathi","year":"2024","journal-title":"Br. J. Haematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e7195","DOI":"10.1002\/cam4.7195","article-title":"Expression and prognostic significance of the PD-1\/PD-L1 pathway in AIDS-related non-Hodgkin lymphoma","volume":"13","author":"Zhao","year":"2024","journal-title":"Cancer Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1002\/hem3.150","article-title":"Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"8","author":"Bower","year":"2024","journal-title":"Hemasphere"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.semdp.2024.05.001","article-title":"Review of immunohistochemistry techniques: Applications, current status, and future perspectives","volume":"41","author":"Mebratie","year":"2024","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-1-4939-8935-5_25","article-title":"An Introduction to the Performance of Immunohistochemistry","volume":"1897","author":"Magaki","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e0307253","DOI":"10.1371\/journal.pone.0307253","article-title":"Immunohistochemistry-based investigation of MYC, BCL2, and Ki-67 protein expression and their clinical impact in diffuse large B-cell lymphoma in upper Northern Thailand","volume":"19","author":"Yimpak","year":"2024","journal-title":"PLoS ONE"},{"key":"ref_50","first-page":"184","article-title":"The immune response to SARS-CoV-2 in people with HIV","volume":"21","author":"Burgers","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s12185-022-03305-z","article-title":"Antibody response to COVID-19 vaccination in patients with lymphoma","volume":"115","author":"Narita","year":"2022","journal-title":"Int. J. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/infdis\/jiad174","article-title":"COVID-19 Vaccination in Patients with Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future","volume":"228","author":"Hall","year":"2023","journal-title":"J. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/404\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:51:19Z","timestamp":1760028679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/3\/404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["v17030404"],"URL":"https:\/\/doi.org\/10.3390\/v17030404","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}